Rumgay H, Ferlay J, de Martel C et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108–118.

Article  PubMed  Google Scholar 

Xia C, Dong X, Li H et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135:584–590.

Article  PubMed  PubMed Central  Google Scholar 

Qi J, Li M, Wang L et al. National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8:e943–e955.

Article  PubMed  Google Scholar 

Ducreux M, Abou-Alfa GK, Bekaii-Saab T, et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO Open. 2023; 8: 101567.

Llovet JM, Kelley RK, Villanueva A et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.

Article  PubMed  Google Scholar 

Marrero JA, Kulik LM, Sirlin CB et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723–750.

Article  PubMed  Google Scholar 

Lominadze Z, Shaik MR, Choi D, Zaffar D, Mishra L, Shetty K. Hepatocellular carcinoma genetic classification. Cancer J. 2023;29:249–258.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Escote X, Fajas L. Metabolic adaptation to cancer growth: from the cell to the organism. Cancer Lett. 2015;356:171–175.

Article  CAS  PubMed  Google Scholar 

Paul B, Lewinska M, Andersen JB. Lipid alterations in chronic liver disease and liver cancer. JHEP Rep. 2022;4:100479.

Article  PubMed  PubMed Central  Google Scholar 

Goodrich JA, Walker D, Lin X et al. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort. JHEP Rep. 2022;4:100550.

Article  PubMed  PubMed Central  Google Scholar 

Ikeda Y, Dabrowski C, Tanaka K. Separation and properties of five distinct acyl-CoA dehydrogenases from rat liver mitochondria. Identification of a new 2-methyl branched chain acyl-CoA dehydrogenase. J Biol Chem. 1983;258:1066–1076.

Article  CAS  PubMed  Google Scholar 

Ikeda Y, Okamura-Ikeda K, Tanaka K. Purification and characterization of short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases from rat liver mitochondria. Isolation of the holo- and apoenzymes and conversion of the apoenzyme to the holoenzyme. J Biol Chem. 1985;260:1311–1325.

Article  CAS  PubMed  Google Scholar 

Lampret BR, Murko S, Debeljak M, Tansek MZ, Fister P, Battelino T. A case report of short-chain acyl-CoA dehydrogenase deficiency (SCADD). Biochem Med (Zagreb). 2015;25:279–284.

Article  PubMed  PubMed Central  Google Scholar 

Kilic M, Senel S, Karaer K, Ceylaner S. Microcephaly and developmental delay caused by short-chain acyl-CoA dehydrogenase deficiency. Turk J Pediatr. 2017;59:708–710.

Article  PubMed  Google Scholar 

Wu Q, Yan T, Chen Y et al. Integrated analysis of expression and prognostic values of Acyl-CoA dehydrogenase short-chain in colorectal cancer. Int J Med Sci. 2021;18:3631–3643.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF and Chen X. beta-Catenin signaling in hepatocellular carcinoma. J Clin Invest. 2022; 132.

Fan Z, Duan J, Wang L et al. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/beta-catenin signaling. Cancer Lett. 2019;450:132–143.

Article  CAS  PubMed  Google Scholar 

Russell JO, Monga SP. Wnt/beta-catenin signaling in liver development, homeostasis, and pathobiology. Annu Rev Pathol. 2018;13:351–378.

Article  CAS  PubMed  Google Scholar 

Shiota G. Role of retinoic acid receptor in steatohepatitis-related tumor formation. J Gastroenterol Hepatol. 2007;22:S101–S107.

Article  CAS  PubMed  Google Scholar 

Planas-Iglesias J, Marin-Lopez MA, Bonet J, Garcia-Garcia J, Oliva B. iLoops: a protein-protein interaction prediction server based on structural features. Bioinformatics. 2013;29:2360–2362.

Article  CAS  PubMed  Google Scholar 

Barrett T, Wilhite SE, Ledoux P et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41:D991–D995.

Article  CAS  PubMed  Google Scholar 

Ru B, Hu J, Zhang N, Wan Q. A novel metabolism-related gene signature in patients with hepatocellular carcinoma. PeerJ. 2023;11:e16335.

Article  PubMed  PubMed Central  Google Scholar 

Liu CP, Zhang JH, Zheng SC, Liu J, Guo JC. A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer. Oncol Rep. 2018;40:2826–2835.

CAS  PubMed  Google Scholar 

Jarde T, Caldefie-Chezet F, Goncalves-Mendes N et al. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer. 2009;16:1197–1210.

Article  CAS  PubMed  Google Scholar 

Liver Cancer Study Group of J. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211:277–287.

Google Scholar 

Liu PH, Huo TI, Miksad RA. Hepatocellular carcinoma with portal vein tumor involvement: best management strategies. Semin Liver Dis. 2018;38:242–251.

Article  CAS  PubMed  Google Scholar 

Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–1255.

Article  PubMed  Google Scholar 

Lee WC, Chou HS, Wu TJ et al. Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis. Clin Proteomics. 2017;14:29.

Article  PubMed  PubMed Central  Google Scholar 

Chen D, Feng X, Lv Z et al. ACADS acts as a potential methylation biomarker associated with the proliferation and metastasis of hepatocellular carcinomas. Aging (Albany NY). 2019;11:8825–8844.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berndt N, Eckstein J, Heucke N, et al. Characterization of Lipid and Lipid Droplet Metabolism in Human HCC. Cells. 2019; 8.

Zhang X, Guo J, Jabbarzadeh Kaboli P et al. Analysis of key genes regulating the warburg effect in patients with gastrointestinal cancers and selective inhibition of this metabolic pathway in liver cancer cells. Onco Targets Ther. 2020;13:7295–7304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Augenlicht LH, Anthony GM, Church TL et al. Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. Cancer Res. 1999;59:6005–6009.

CAS  PubMed  Google Scholar 

Bratslavsky G, Sudarshan S, Neckers L, Linehan WM. Pseudohypoxic pathways in renal cell carcinoma. Clin Cancer Res. 2007;13:4667–4671.

Article  CAS  PubMed  Google Scholar 

Huang D, Li T, Li X et al. HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. Cell Rep. 2014;8:1930–1942.

Article  CAS  PubMed  Google Scholar 

Longo M, Paolini E, Meroni M and Dongiovanni P. Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC. Int J Mol Sci. 2021; 22.

Chehrazi-Raffle A, Dorff TB, Pal SK and Lyou Y. Wnt/beta-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma. Cancers (Basel). 2021; 13.

He S, Tang S. WNT/beta-catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020;132:110851.

Article